TBscore II: Refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis
- 5 July 2013
- journal article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Infectious Diseases
- Vol. 45 (11), 825-836
- https://doi.org/10.3109/00365548.2013.826876
Abstract
Background: The TBscore, based on simple signs and symptoms, was introduced to predict unsuccessful outcome in tuberculosis patients on treatment. A recent inter-observer variation study showed profound variation in some variables. Further, some variables depend on a physician assessing them, making the score less applicable. The aim of the present study was to simplify the TBscore. Methods: Inter-observer variation assessment and exploratory factor analysis were combined to develop a simplified score, the TBscore II. To validate TBscore II we assessed the association between start score and failure (i.e. death or treatment failure), responsiveness using Cohen's effect size, and the relationship between severity class at treatment start and a decrease < 25% in score from the start until the end of the second treatment month and subsequent mortality. Results: We analyzed data from 1070 Guinean (2003–2012) and 432 Ethiopian (2007–2012) pulmonary tuberculosis patients. For the refined score, items with less than substantial agreement (κ ≤ 0.6) and/or not associated with the underlying constructs were excluded. Items kept were: cough, dyspnea, chest pain, anemia, body mass index (BMI) < 18 kg/m2, BMI < 16 kg/m2, mid upper arm circumference (MUAC) < 220 mm, and MUAC < 200 mm. The effect sizes for the change between the start of treatment and the 2-month follow-up were 0.51 in Guinea-Bissau and 0.68 in Ethiopia, and for the change between the start of treatment and the end of treatment were 0.68 in Guinea-Bissau and 0.74 in Ethiopia. Severity class placement at treatment start predicted failure (p < 0.001 Guinea-Bissau, p = 0.208 Ethiopia). Inability to decrease at least 25% in score was associated with a higher failure rate during the remaining 4 months of treatment (p = 0.063 Guinea-Bissau, p = 0.008 Ethiopia). Conclusion: The TBscore II could be a useful monitoring tool, aiding triage at the beginning of treatment and during treatment.Keywords
This publication has 36 references indexed in Scilit:
- Gut Hormones, Appetite Suppression and Cachexia in Patients with Pulmonary TBPLOS ONE, 2013
- Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort studyBMJ Open, 2012
- Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment responseTuberculosis, 2012
- Old and New Ideas for Data Screening and Assumption Testing for Exploratory and Confirmatory Factor AnalysisFrontiers in Psychology, 2012
- Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisBMC Infectious Diseases, 2011
- Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Factors associated with deaths among pulmonary tuberculosis patients: a case-control study with secondary dataJournal of Epidemiology and Community Health, 2009
- Estimation of undernutrition and mean calorie intake in Africa: methodology, findings and implicationsInternational Journal of Health Geographics, 2009
- Inter-observer variation of the Bandim TB-scoreScandinavian Journal of Infectious Diseases, 2009
- Methods for assessing responsiveness: a critical review and recommendationsJournal of Clinical Epidemiology, 2000